MAPT and Alzheimer disease: To ascertain whether the AD phenotypes of Aβ aggregation and Tau hyperphosphorylation are generalizable to fAD organoids from different sources, rather than being a phenomenon of the APPDp1-1 line, we examined additional organoids created from patient-derived and healthy control iPSCs (S1 Table).